Abivax (ABVX) Free Cash Flow (2024 - 2026)
Abivax (ABVX) posted quarterly Free Cash Flow of -$59.1 million for Q1 2026, down 69.01% year-over-year from -$190.6 million in Q1 2025, and down 116.94% quarter-over-quarter from -$27.2 million in Q4 2025.
Abivax (ABVX) Free Cash Flow (2024 - 2026) Analysis & Trends
Abivax's Free Cash Flow history runs 3 years deep, the most recent figure standing at -$59.1 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 69.01% year-over-year to -$59.1 million; the TTM figure through Mar 2026 stood at -$207.4 million (down 25.96% YoY), while the FY2025 annual figure was -$187.7 million, down 13.51% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$59.1 million, down from -$27.2 million in the prior quarter.
- The five-year high for Free Cash Flow was -$27.2 million in Q4 2025, with the low at -$83.3 million in Q3 2025.
- The 3-year median for Free Cash Flow is -$37.7 million (2024), against an average of -$45.5 million.
- Peak annual rise in Free Cash Flow reached 30.22% in 2025, while the deepest fall reached 116.38% in 2025.
- Abivax's Free Cash Flow stood at -$37.1 million in 2024, then increased by 26.62% to -$27.2 million in 2025, then tumbled by 116.94% to -$59.1 million in 2026.
- Business Quant data shows ABVX's Free Cash Flow at -$59.1 million in Q1 2026, -$27.2 million in Q4 2025, and -$83.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -389.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 437.80 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 477.44 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 292.04 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - | -59.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.08 Mn |
| Mar 31, 2026 | -59.08 Mn |
| Dec 31, 2025 | -27.23 Mn |
| Dec 31, 2025 | -27.23 Mn |
| Sep 30, 2025 | -83.34 Mn |
| Sep 30, 2025 | -83.34 Mn |
| Jun 30, 2025 | -37.72 Mn |
| Jun 30, 2025 | -37.72 Mn |
| Mar 31, 2025 | -34.96 Mn |
| Mar 31, 2025 | -34.96 Mn |
| Dec 31, 2024 | -37.11 Mn |
| Dec 31, 2024 | -37.11 Mn |
| Sep 30, 2024 | -38.52 Mn |
| Sep 30, 2024 | -38.52 Mn |
| Jun 30, 2024 | -54.06 Mn |
| Jun 30, 2024 | -54.06 Mn |
| Mar 31, 2024 | -37.74 Mn |
| Mar 31, 2024 | -37.74 Mn |